Product
Levilimab
1 clinical trial
1 indication
Indication
Rheumatoid ArthritisClinical trial
A Two-Stage Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Various Doses of Levilimab When Administered Intravenously and Subcutaneously to Healthy Subjects and Subjects With Active Rheumatoid ArthritisStatus: Active (not recruiting), Estimated PCD: 2024-09-01